Your session is about to expire
← Back to Search
CAPABLE Transitions for Dementia
N/A
Waitlist Available
Led By Adam Simning, MD, PhD
Research Sponsored by University of Rochester
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up month 3 to month 6 (3 months)
Awards & highlights
Summary
This trial is testing a new intervention to help with the transition of care for elderly patients discharged from a hospital or post-acute care facility. The intervention consists of in-home visits from an occupational therapist, nurse, and handyman over 3-4 months. The goal is to improve functioning and safety at home. A total of 60 older adults with and without dementia will be recruited for the study.
Eligible Conditions
- Dementia
- Transition Care
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ month 3 to month 6 (3 months)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~month 3 to month 6 (3 months)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Data Completeness on Clinical Outcomes
Percentage of Enrolled Participants That Are Retained
Percentage of Participants Screened as Eligible
+3 moreSecondary outcome measures
Health Services Use, Mean
Health Services Use, Percentage
Home Time in Days (From the 3 to 6 Month Period)
+2 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: CAPABLE TransitionsExperimental Treatment2 Interventions
Older adults admitted to University of Rochester Medicine Home Care with and without dementia will receive care as usual as well as CAPABLE-trained occupational therapy, registered nurse, and handyman services delivered over 3-4 months.
Group II: Care As UsualActive Control1 Intervention
Older adults admitted to University of Rochester Medicine Home Care (a Medicare-certified home health agency) with and without dementia will receive care as usual.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
CAPABLE Transitions
2021
N/A
~40
Home Health Agency Care
2021
N/A
~40
Find a Location
Who is running the clinical trial?
National Institute on Aging (NIA)NIH
1,704 Previous Clinical Trials
28,033,226 Total Patients Enrolled
278 Trials studying Dementia
23,628,832 Patients Enrolled for Dementia
University of RochesterLead Sponsor
847 Previous Clinical Trials
535,366 Total Patients Enrolled
6 Trials studying Dementia
1,232 Patients Enrolled for Dementia
Adam Simning, MD, PhD5.01 ReviewsPrincipal Investigator - University of Rochester
University of Rochester
5Patient Review
They were prompt, courteous, and seemed to genuinely care. I felt like I could trust them.
Share this study with friends
Copy Link
Messenger